Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo

Go back to Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo
Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

Par Pharmaceutical Cos., Inc. (NYSE: PRX) Delayed: 49.98 --0 (-0%)
Previous Close $49.98    52 Week High $52.33 
Open $0.02    52 Week Low $26.57 
Day High $49.98    P/E 24.26 
Day Low $49.98    EPS $2.06 
Volume 7,000       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.58 +0.12 (0.33%)
Previous Close $36.46    52 Week High $66.55 
Open $36.47    52 Week Low $37.82 
Day High $37.25    P/E N/A 
Day Low $36.34    EPS $0.00 
Volume 6,197,499       

Watson Pharmaceuticals, Inc. (NYSE: WPI) Delayed: 85.73 --0 (-0%)
Previous Close $85.73    52 Week High $91.47 
Open $16.30    52 Week Low $57.16 
Day High $85.73    P/E 66.46 
Day Low $85.73    EPS $1.29 
Volume 3,625